SEC Tracker
Get the app

Cortexyme IRLA

Cortexyme FY 2020: net loss $76.8M

Form
10-K
Filed
Period
Importance
Notable
Document
10-K

Key figures from this report

These are the numbers Cortexyme reported for the year ended Dec 31, 2020, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Net income−$76.8MNo year-earlier figure tagged10-K income statement, on EDGAR
  2. Cash and cash equivalents$66.8MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
  3. Cash from operations−$50.8MNo year-earlier figure tagged10-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Cortexyme files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Veru VERU public float $64M, Mar 31, 2025, over 18 months old
  2. Lifevantage LFVN public float $64M, Dec 31, 2025
  3. Whitehawk Therapeutics WHWK public float $65M, Jun 30, 2025
  4. Medicinova MNOV public float $62M, Jun 30, 2025
  5. Corbus Pharmaceuticals Holdings CRBP public float $68M, Jun 30, 2025